Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior

Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior

10.1021/acsptsci.0c00064

Saved in:
Bibliographic Details
Main Authors: Wang, Yanxin, Chiou, Yi-Shiou, Chong, Qing-Yun, Zhang, Mengyi, Rangappa, Kanchuragoppal S, Ma, Lan, Zhu, Tao, Kumar, Alan Prem, Huang, Ruby Yun-Ju, Pandey, Vijay, Basappa, Lobie, Peter E
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Language:English
Published: AMER CHEMICAL SOC 2023
Subjects:
Science & Technology
Life Sciences & Biomedicine
Chemistry, Medicinal
Pharmacology & Pharmacy
BAD phosphorylation
NPB
ovarian cancer
cisplatin resistance
cancer stem cell
PHASE-III TRIAL
INTERGROUP TRIAL
CARBOPLATIN-PACLITAXEL
1ST-LINE TREATMENT
SURVIVAL
PROTEIN
MECHANISMS
THERAPY
DEATH
DRUG
Online Access:https://scholarbank.nus.edu.sg/handle/10635/245936
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English

Internet

https://scholarbank.nus.edu.sg/handle/10635/245936

Similar Items